US 7563892
Prodrugs of 2,4 pyrimidinediamine compounds and their uses
granted A61KA61K31/5383A61K31/675
Quick answer
US patent 7563892 (Prodrugs of 2,4 pyrimidinediamine compounds and their uses) held by Rigel Pharmaceuticals, Inc. expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/5383, A61K31/675, A61P, A61P1/04